HealthEquity (US.HQY)
Capital Allocation Audit · Period: 2013 – 2027
Key Metrics
US.HQY · YoY: 2027 Q1 vs 2026 Q1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 83.3% | ↑ |
| ROE | 3.4% | ↑ |
| Cash Conversion | 140.5% | ↑ |
| D/E Ratio | 0.48 | ↑ |
| Gross Margin | 72.3% | ↑ |
US.HQY (HealthEquity) | YoY: 2027 Q1 vs 2026 Q1 Metric Value YoY ---------------------------- FCF Conversion 83.3% ↑ ROE 3.4% ↑ Cash Conversion 140.5% ↑ D/E Ratio 0.48 ↑ Gross Margin 72.3% ↑
Key Metrics
US.HQY (HealthEquity) | YoY: 2027 Q1 vs 2026 Q1
Metric Value YoY----------------------------FCF Conversion 83.3% ↑ROE 3.4% ↑Cash Conversion 140.5% ↑D/E Ratio 0.48 ↑Gross Margin 72.3% ↑Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies